These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4904615)

  • 21. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 22. Antilymphocyte serum and procarbazine compared as immunosuppressants in mice, rats and rabbits.
    Stewart PB; Bell R
    Laval Med; 1970 Apr; 41(4):599-606. PubMed ID: 4929813
    [No Abstract]   [Full Text] [Related]  

  • 23. Leukemia L 1210 homograft in Swiss mice: immunologic, cellular and chemotherapeutic responses.
    Prince HN; Grunberg E
    J Immunol; 1969 Aug; 103(2):324-33. PubMed ID: 5803789
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of antilymphocyte serum in transplantation (literature review)].
    Govallo VI; Kosmiadi GA
    Khirurgiia (Mosk); 1971 Jan; 47(1):142-6. PubMed ID: 4930584
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppressive effect of antisera to subcellular lymphocyte fractions.
    Moynihan PC; Grogan JB
    Surg Gynecol Obstet; 1969 Sep; 129(3):551-5. PubMed ID: 4897995
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of cells and serum of donors immunized with recipients' leukocytes on transplantation immunity in rabbits].
    Novikov DK; Adamenko GP; Novikova VI
    Biull Eksp Biol Med; 1972 Aug; 73(8):58-62. PubMed ID: 4564366
    [No Abstract]   [Full Text] [Related]  

  • 28. Notes on the preparation and assay of anti-lymphocytic serum for use in mice.
    Jooste SV; Lance EM; Levey RH; Medawar PB; Ruszkiewicz M; Sharman R; Taub RN
    Immunology; 1968 Nov; 15(5):697-705. PubMed ID: 4880356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E; Bennett M
    Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in rabbit antimouse lymphocyte sera caused by lymphocytes of differing origins in the immunizing inocula.
    Miller J; Tanner D; Cohn R
    Transplantation; 1970 Apr; 9(4):352-65. PubMed ID: 4927383
    [No Abstract]   [Full Text] [Related]  

  • 31. Further studies on the biological properties of guinea-pig IgG1 antibodies: anti-lymphocyte antibodies.
    Vuagnat P
    Immunology; 1974 Sep; 27(3):351-7. PubMed ID: 4213122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic antibodies after skin allotransplantation in rabbits.
    Matej H
    Arch Immunol Ther Exp (Warsz); 1970; 18(1):29-41. PubMed ID: 4908940
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of subcellular lymphocyte fractions to raise anti- lymphocyte serum.
    Lance EM; Ford P; Ruskziewicz M
    Fed Proc; 1970; 29(1):106-7. PubMed ID: 4904616
    [No Abstract]   [Full Text] [Related]  

  • 34. Assay for the immunosuppressive capacity of antilymphocyte serum. II. Nature and specificity of opsonizing antibody.
    Martin WJ
    J Immunol; 1969 Nov; 103(5):990-9. PubMed ID: 5350978
    [No Abstract]   [Full Text] [Related]  

  • 35. Modification of the immunosuppressive effects of rabbit antimouse lymphocyte serum by a thymic humoral factor: thymosin.
    Quint J; Hardy MA; Monaco AP
    Surg Forum; 1969; 20():252-4. PubMed ID: 4910588
    [No Abstract]   [Full Text] [Related]  

  • 36. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR; Faulkner HW; Burde RM
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract]   [Full Text] [Related]  

  • 37. Perspectives of immunosuppression.
    Balner H
    Transplant Proc; 1971 Mar; 3(1):949-52. PubMed ID: 4941149
    [No Abstract]   [Full Text] [Related]  

  • 38. [The feasibility of prolonging the visability of allotransplants by using antilymphocytic and antithrombocytic sera].
    Khundanov LI; Verbitskiĭ MSh; Artsimovich NG; Kipervasser EM; Lagutina NIa
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):42-50. PubMed ID: 4558981
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of the development of primary antibacterial immunity by heterologous anti-lymphocyte serum.
    Réthy L; Padányi M
    Acta Vet Acad Sci Hung; 1969; 19(4):405-15. PubMed ID: 4909689
    [No Abstract]   [Full Text] [Related]  

  • 40. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.
    Waltman SR; Burde RM; Faulkner HW
    Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.